Home About us Editorial board Ahead of print Browse Articles Search Submit article Instructions Subscribe Contacts Login 
  • Users Online: 151
  • Home
  • Print this page
  • Email this page

    Article Cited by others


Alpha-synuclein structure, functions, and interactions

Emamzadeh Fatemeh Nouri

Year : 2016| Volume: 21| Issue : 1 | Page no: 29-29

   This article has been cited by
1 14-3-3 mitigates alpha-synuclein aggregation and toxicity in the in vivo preformed fibril model
Rachel Underwood,Mary Gannon,Aneesh Pathak,Navya Kapa,Sidhanth Chandra,Alyssa Klop,Talene A. Yacoubian
Acta Neuropathologica Communications. 2021; 9(1)
[Pubmed]  [Google Scholar] [DOI]
2 Oxidative stress factors in Parkinson’s disease
Jolanta Dorszewska,Marta Kowalska,Michal Prendecki,Thomas Piekut,Joanna Kozlowska,Wojciech Kozubski
Neural Regeneration Research. 2021; 16(7): 1383
[Pubmed]  [Google Scholar] [DOI]
3 Gut-Brain Axis in Parkinsonæs disease Etiology: The Role of Lipopolysaccharide
Dipita Bhattacharyya,Anirban Bhunia
Chemistry and Physics of Lipids. 2020; : 105029
[Pubmed]  [Google Scholar] [DOI]
4 Aggregation of biologically important peptides and proteins: inhibition or acceleration depending on protein and metal ion concentrations
Benjamin Gabriel Poulson,Kacper Szczepski,Joanna Izabela Lachowicz,Lukasz Jaremko,Abdul-Hamid Emwas,Mariusz Jaremko
RSC Advances. 2020; 10(1): 215
[Pubmed]  [Google Scholar] [DOI]
5 Overexpression of a-Synuclein Reorganises Growth Factor Profile of Human Astrocytes
Büsra Sengül,Erdinç Dursun,Alexei Verkhratsky,Duygu Gezen-Ak
Molecular Neurobiology. 2020;
[Pubmed]  [Google Scholar] [DOI]
6 From Seeds to Fibrils and Back: Fragmentation as an Overlooked Step in the Propagation of Prions and Prion-Like Proteins
Cristóbal Marrero-Winkens,Charu Sankaran,Hermann M. Schätzl
Biomolecules. 2020; 10(9): 1305
[Pubmed]  [Google Scholar] [DOI]
7 Viral-based rodent and nonhuman primate models of multiple system atrophy: Fidelity to the human disease
David J. Marmion,Angela A. Rutkowski,Diptaman Chatterjee,Benjamin M. Hiller,Milton H. Werner,Erwan Bezard,Deniz Kirik,Thomas McCown,Steven J. Gray,Jeffrey H. Kordower
Neurobiology of Disease. 2020; : 105184
[Pubmed]  [Google Scholar] [DOI]
8 The contribution of Parkin, PINK1 and DJ-1 genes to selective neuronal degeneration in Parkinsonæs disease
Marc van der Vlag,Robbert Havekes,Pim R. A. Heckman
European Journal of Neuroscience. 2020;
[Pubmed]  [Google Scholar] [DOI]
9 Genetics of synucleins in neurodegenerative diseases
José Brás,Elizabeth Gibbons,Rita Guerreiro
Acta Neuropathologica. 2020;
[Pubmed]  [Google Scholar] [DOI]
10 Endosomal-Lysosomal Processing of Neurodegeneration-Associated Proteins in Astrocytes
Ching-On Wong
International Journal of Molecular Sciences. 2020; 21(14): 5149
[Pubmed]  [Google Scholar] [DOI]
11 Linking Alpha-Synuclein to the Actin Cytoskeleton: Consequences to Neuronal Function
Marina I. Oliveira da Silva,Márcia A. Liz
Frontiers in Cell and Developmental Biology. 2020; 8
[Pubmed]  [Google Scholar] [DOI]
12 Alleviating toxic a-Synuclein accumulation by membrane depolarization: evidence from an in vitro model of Parkinson’s disease
Alysia Ross,Viktoria Xing,Ting Ting Wang,Samantha C. Bureau,Giovana A. Link,Teresa Fortin,Hui Zhang,Shawn Hayley,Hongyu Sun
Molecular Brain. 2020; 13(1)
[Pubmed]  [Google Scholar] [DOI]
13 Unravelling the effect of N(e)-(carboxyethyl)lysine on the conformation, dynamics and aggregation propensity of a-synuclein
Laura Mariño,Rafael Ramis,Rodrigo Casasnovas,Joaquín Ortega-Castro,Bartolomé Vilanova,Juan Frau,Miquel Adrover
Chemical Science. 2020; 11(12): 3332
[Pubmed]  [Google Scholar] [DOI]
14 6-Hydroxydopamine: a far from simple neurotoxin
Damir Varešlija,Keith F. Tipton,Gavin P. Davey,Andrew G. McDonald
Journal of Neural Transmission. 2020;
[Pubmed]  [Google Scholar] [DOI]
15 Using NMR spectroscopy to investigate the role played by copper in prion diseases
Rawiah A. Alsiary,Mawadda Alghrably,Abdelhamid Saoudi,Suliman Al-Ghamdi,Lukasz Jaremko,Mariusz Jaremko,Abdul-Hamid Emwas
Neurological Sciences. 2020;
[Pubmed]  [Google Scholar] [DOI]
16 Cynomolgus Monkeys With Spontaneous Type-2-Diabetes-Mellitus-Like Pathology Develop Alpha-Synuclein Alterations Reminiscent of Prodromal Parkinson’s Disease and Related Diseases
Yan Sun,Chuang Guo,Lin Yuan,Wen Li,Zhan-You Wang,Feng Yue,Jia-Yi Li
Frontiers in Neuroscience. 2020; 14
[Pubmed]  [Google Scholar] [DOI]
17 Eye lens crystallin proteins inhibit the autocatalytic amyloid amplification nature of mature a-synuclein fibrils
Ricardo Gaspar,Tommy Garting,Anna Stradner,Peter Schuck
PLOS ONE. 2020; 15(6): e0235198
[Pubmed]  [Google Scholar] [DOI]
18 Identifying the mechanisms of a-synuclein-mediated cytotoxicity in Parkinson’s disease: new insights from a bioinformatics-based approach
Sankha S Chakrabarti,Venkatadri S Sunder,Upinder Kaur,Sapna Bala,Priyanka Sharma,Manjari Kiran,Ravindra K Rawal,Sasanka Chakrabarti
Future Neurology. 2020; : FNL49
[Pubmed]  [Google Scholar] [DOI]
19 Lipopolysaccharide Animal Models of Parkinson’s Disease: Recent Progress and Relevance to Clinical Disease
Isaac Deng,Frances Corrigan,Guangxi Zhai,Xin-Fu Zhou,Larisa Bobrovskaya
Brain, Behavior, & Immunity - Health. 2020; : 100060
[Pubmed]  [Google Scholar] [DOI]
20 CSF a-synuclein correlates with CSF neurogranin in late-life depression
Davide Bruno,Chelsea Reichert Plaska,Daniel P. A. Clark,Henrik Zetterberg,Kaj Blennow,Marcel M. Verbeek,Nunzio Pomara
International Journal of Neuroscience. 2020; : 1
[Pubmed]  [Google Scholar] [DOI]
21 pH-Dependent Aggregation in Intrinsically Disordered Proteins Is Determined by Charge and Lipophilicity
Jaime Santos,Valentín Iglesias,Juan Santos-Suárez,Marco Mangiagalli,Stefania Brocca,Irantzu Pallarès,Salvador Ventura
Cells. 2020; 9(1): 145
[Pubmed]  [Google Scholar] [DOI]
22 Alpha-Synuclein Physiology and Pathology: A Perspective on Cellular Structures and Organelles
Luis D. Bernal-Conde,Rodrigo Ramos-Acevedo,Mario A. Reyes-Hernández,Andrea J. Balbuena-Olvera,Ishbelt D. Morales-Moreno,Rubén Argüero-Sánchez,Birgitt Schüle,Magdalena Guerra-Crespo
Frontiers in Neuroscience. 2020; 13
[Pubmed]  [Google Scholar] [DOI]
23 Anti-Parkinsonæs disease activity of phenolic acids from Eucommia ulmoides Oliver leaf extracts and their autophagy activation mechanism
Shanshan Zhang,Zhangping Yu,Jingyu Xia,Xuanming Zhang,Kechun Liu,Attila Sik,Meng Jin
Food & Function. 2020;
[Pubmed]  [Google Scholar] [DOI]
24 Unraveling the NaCl Concentration Effect on the First Stages of a-Synuclein Aggregation
Rafael Ramis,Joaquín Ortega-Castro,Bartolomé Vilanova,Miquel Adrover,Juan Frau
Biomacromolecules. 2020;
[Pubmed]  [Google Scholar] [DOI]
25 Looking Beyond the Core: The Role of Flanking Regions in the Aggregation of Amyloidogenic Peptides and Proteins
Sabine M. Ulamec,David J. Brockwell,Sheena E. Radford
Frontiers in Neuroscience. 2020; 14
[Pubmed]  [Google Scholar] [DOI]
26 Antibody Fragments as Tools for Elucidating Structure-Toxicity Relationships and for Diagnostic/Therapeutic Targeting of Neurotoxic Amyloid Oligomers
André L. B. Bitencourt,Raquel M. Campos,Erika N. Cline,William L. Klein,Adriano Sebollela
International Journal of Molecular Sciences. 2020; 21(23): 8920
[Pubmed]  [Google Scholar] [DOI]
27 Demonstration of brain region-specific neuronal vulnerability in human iPSC-based model of familial Parkinson’s disease
Razvan-Marius Brazdis,Julian E Alecu,Daniel Marsch,Annika Dahms,Katrin Simmnacher,Sandra Lörentz,Anna Brendler,Yanni Schneider,Franz Marxreiter,Laurent Roybon,Beate Winner,Wei Xiang,Iryna Prots
Human Molecular Genetics. 2020;
[Pubmed]  [Google Scholar] [DOI]
28 Identification of on- and off-pathway oligomers in amyloid fibril formation
Alexander J. Dear,Georg Meisl,Andela Šaric,Thomas C. T. Michaels,Magnus Kjaergaard,Sara Linse,Tuomas P. J. Knowles
Chemical Science. 2020;
[Pubmed]  [Google Scholar] [DOI]
29 Remodeling microglia to a protective phenotype in Parkinson’s disease?
Ifeoluwa Oluleke Awogbindin,Ismail Ogunbayode Ishola,Marie-Kim St-Pierre,Micaël Carrier,Julie C. Savage,Thérèse Di Paolo,Marie-Ève Tremblay
Neuroscience Letters. 2020; : 135164
[Pubmed]  [Google Scholar] [DOI]
30 The Antiaggregative and Antiamyloidogenic Properties of Nanoparticles: A Promising Tool for the Treatment and Diagnostics of Neurodegenerative Diseases
Monika Pichla,Grzegorz Bartosz,Izabela Sadowska-Bartosz,Marco Malaguti
Oxidative Medicine and Cellular Longevity. 2020; 2020: 1
[Pubmed]  [Google Scholar] [DOI]
31 Intracellular Alpha-Synuclein and Immune Cell Function
Veselin Grozdanov,Karin M. Danzer
Frontiers in Cell and Developmental Biology. 2020; 8
[Pubmed]  [Google Scholar] [DOI]
32 Mitochondrial Protein Import Dysfunction in Pathogenesis of Neurodegenerative Diseases
Shweta Goyal,Rajnish Kumar Chaturvedi
Molecular Neurobiology. 2020;
[Pubmed]  [Google Scholar] [DOI]
33 Novel Immunotherapeutic Approaches to Target Alpha-Synuclein and Related Neuroinflammation in Parkinson’s Disease
Maria Zella,Judith Metzdorf,Friederike Ostendorf,Fabian Maass,Siegfried Muhlack,Ralf Gold,Aiden Haghikia,Lars Tönges
Cells. 2019; 8(2): 105
[Pubmed]  [Google Scholar] [DOI]
34 Prion and Prion-Like Protein Strains: Deciphering the Molecular Basis of Heterogeneity in Neurodegeneration
Carlo Scialò,Elena De Cecco,Paolo Manganotti,Giuseppe Legname
Viruses. 2019; 11(3): 261
[Pubmed]  [Google Scholar] [DOI]
35 Reprint of “Ganglioside lipids accelerate a-synuclein amyloid formation”
Ricardo Gaspar,Jon Pallbo,Ulrich Weininger,Sara Linse,Emma Sparr
Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics. 2019;
[Pubmed]  [Google Scholar] [DOI]
36 Plasma a -synuclein levels are increased in patients with obstructive sleep apnea syndrome
Hao-Lun Sun,Bin-Lu Sun,Dong-Wan Chen,Yang Chen,Wei-Wei Li,Man-Yu Xu,Ying-Ying Shen,Zhi-Qiang Xu,Yan-Jiang Wang,Xian-Le Bu
Annals of Clinical and Translational Neurology. 2019;
[Pubmed]  [Google Scholar] [DOI]
37 Lipids at the Crossroad of a-Synuclein Function and Dysfunction: Biological and Pathological Implications
Natalia P. Alza,Pablo A. Iglesias González,Melisa A. Conde,Romina M. Uranga,Gabriela A. Salvador
Frontiers in Cellular Neuroscience. 2019; 13
[Pubmed]  [Google Scholar] [DOI]
38 Prion Efficiently Replicates in a-Synuclein Knockout Mice
Edoardo Bistaffa,Martina Rossi,Chiara Maria Giulia De Luca,Federico Cazzaniga,Olga Carletta,Ilaria Campagnani,Fabrizio Tagliavini,Giuseppe Legname,Giorgio Giaccone,Fabio Moda
Molecular Neurobiology. 2019;
[Pubmed]  [Google Scholar] [DOI]
39 The Role of Aptamer Loaded Exosome Complexes in the Neurodegenerative Diseases
Simranjeet Singh Sekhon,Gna Ahn,Ga-Young Park,Dae-Young Park,Sang-Hee Lee,Ji-Young Ahn,Yang-Hoon Kim
Toxicology and Environmental Health Sciences. 2019; 11(2): 85
[Pubmed]  [Google Scholar] [DOI]
40 Upcoming diagnostic biomarkers with promising prospects in neurological disorders
Wasim Ahmad,Abuzer Ali,Amena Ali,Sana Khan,Saba Khan,Ibraheem Husain
Clinical and Experimental Pharmacology and Physiology. 2019;
[Pubmed]  [Google Scholar] [DOI]
41 a-synuclein-lipoprotein interactions and elevated ApoE level in cerebrospinal fluid from Parkinsonæs disease patients
Wojciech Paslawski,Justyna Zareba-Paslawska,Xiaoqun Zhang,Katharina Hölzl,Henrik Wadensten,Mohammadreza Shariatgorji,Shorena Janelidze,Oskar Hansson,Lars Forsgren,Per E. Andrén,Per Svenningsson
Proceedings of the National Academy of Sciences. 2019; : 201821409
[Pubmed]  [Google Scholar] [DOI]
42 Recent advances of induced pluripotent stem cells application in neurodegenerative diseases
Nashwa Amin,Xiaoning Tan,Qiannan Ren,Ning Zhu,Benson O.A. Botchway,Zhiying Hu,Marong Fang
Progress in Neuro-Psychopharmacology and Biological Psychiatry. 2019; 95: 109674
[Pubmed]  [Google Scholar] [DOI]
43 Mechanical and thermodynamic properties of Aß42, Aß40, and a-synuclein fibrils: a coarse-grained method to complement experimental studies
Adolfo B Poma,Horacio V Guzman,Mai Suan Li,Panagiotis E Theodorakis
Beilstein Journal of Nanotechnology. 2019; 10: 500
[Pubmed]  [Google Scholar] [DOI]
44 Implications of alpha-synuclein nitration at tyrosine 39 in methamphetamine-induced neurotoxicity in vitro and in vivo
Hong-Hua Qiao,Lin-Nan Zhu,Yue Wang,Jia-Liang Hui,Wei-Bing Xie,Chao Liu,Ling Chen,Ping-Ming Qiu
Neural Regeneration Research. 2019; 14(2): 319
[Pubmed]  [Google Scholar] [DOI]
45 Early stages of Parkinson’s disease: aspects of the diagnosis and therapy
A. A. Pilipovich
Medical Council. 2019; (18): 61
[Pubmed]  [Google Scholar] [DOI]
46 In-vitro and in-silico investigation of protective mechanisms of crocin against E46K a-synuclein amyloid formation
Marzieh Ghasemi Tigan,Arezou Ghahghaei,Milad Lagzian
Molecular Biology Reports. 2019;
[Pubmed]  [Google Scholar] [DOI]
47 Naphthoquinone Tryptophan Hybrids: A Promising Small Molecule Scaffold for Mitigating Aggregation of Amyloidogenic Proteins and Peptides
Guru KrishnaKumar Viswanathan,Ashim Paul,Ehud Gazit,Daniel Segal
Frontiers in Cell and Developmental Biology. 2019; 7
[Pubmed]  [Google Scholar] [DOI]
48 Alpha synuclein in hematopoiesis and immunity
Yu Pei,Robert W. Maitta
Heliyon. 2019; 5(10): e02590
[Pubmed]  [Google Scholar] [DOI]
49 Physiological, molecular and genetic aspects of alpha-synuclein and its correlation with high alcohol consumption
Tania Yadira Martínez-Rodríguez,Mauricio Rey-Buitrago
Revista de la Facultad de Medicina. 2019; 67(3): 315
[Pubmed]  [Google Scholar] [DOI]
50 Deciphering the anti-Parkinson’s activity of sulphated polysaccharides from Chlamydomonas reinhardtii on the a-Synuclein mutants A30P, A53T, E46K, E57K and E35K
Gitanjali P Panigrahi,Ankita R Rane,Sirisha L Vavilala,Sinjan Choudhary
The Journal of Biochemistry. 2019;
[Pubmed]  [Google Scholar] [DOI]
51 Selective vulnerability in a-synucleinopathies
Javier Alegre-Abarrategui,Katherine R. Brimblecombe,Rosalind F. Roberts,Elisavet Velentza-Almpani,Bension S. Tilley,Nora Bengoa-Vergniory,Christos Proukakis
Acta Neuropathologica. 2019;
[Pubmed]  [Google Scholar] [DOI]
52 A Coarse-Grained Molecular Dynamics Approach to the Study of the Intrinsically Disordered Protein a-Synuclein
Rafael Ramis,Joaquín Ortega-Castro,Rodrigo Casasnovas,Laura Mariño,Bartolomé Vilanova,Miquel Adrover,Juan Frau
Journal of Chemical Information and Modeling. 2019; 59(4): 1458
[Pubmed]  [Google Scholar] [DOI]
53 Mass Spectrometric Analysis of Lewy Body-Enriched a-Synuclein in Parkinson’s Disease
Payel Bhattacharjee,Annika Öhrfelt,Tammaryn Lashley,Kaj Blennow,Ann Brinkmalm,Henrik Zetterberg
Journal of Proteome Research. 2019;
[Pubmed]  [Google Scholar] [DOI]
54 Insights into the Molecular Mechanisms of Alzheimer’s and Parkinson’s Diseases with Molecular Simulations: Understanding the Roles of Artificial and Pathological Missense Mutations in Intrinsically Disordered Proteins Related to Pathology
Orkid Coskuner-Weber,Vladimir Uversky
International Journal of Molecular Sciences. 2018; 19(2): 336
[Pubmed]  [Google Scholar] [DOI]
55 Cellular Proteostasis in Neurodegeneration
Alberim Kurtishi,Benjamin Rosen,Ketan S. Patil,Guido W. Alves,Simon G. Møller
Molecular Neurobiology. 2018;
[Pubmed]  [Google Scholar] [DOI]
56 Parkinson’s Disease: Biomarkers, Treatment, and Risk Factors
Fatemeh N. Emamzadeh,Andrei Surguchov
Frontiers in Neuroscience. 2018; 12
[Pubmed]  [Google Scholar] [DOI]
57 Crucial role of protein oligomerization in the pathogenesis of Alzheimeræs and Parkinsonæs diseases
Minee L. Choi,Sonia Gandhi
The FEBS Journal. 2018;
[Pubmed]  [Google Scholar] [DOI]
58 Clearing Extracellular Alpha-Synuclein from Cerebrospinal Fluid: A New Therapeutic Strategy in Parkinson’s Disease
Manuel Menéndez-González,Huber Padilla-Zambrano,Cristina Tomás-Zapico,Benjamin García
Brain Sciences. 2018; 8(4): 52
[Pubmed]  [Google Scholar] [DOI]
59 Salt-bridge dynamics in intrinsically disordered proteins: A trade-off between electrostatic interactions and structural flexibility
Sankar Basu,Parbati Biswas
Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics. 2018; 1866(5-6): 624
[Pubmed]  [Google Scholar] [DOI]
60 The role of posttranslational modifications of a-synuclein and LRRK2 in Parkinsonæs disease: Potential contributions of environmental factors
Edward Pajarillo,Asha Rizor,Jayden Lee,Michael Aschner,Eunsook Lee
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 2018;
[Pubmed]  [Google Scholar] [DOI]
61 The Cellular Environment Affects Monomeric a-Synuclein Structure
Amberley D. Stephens,Maria Zacharopoulou,Gabriele S. Kaminski Schierle
Trends in Biochemical Sciences. 2018;
[Pubmed]  [Google Scholar] [DOI]
62 Alpha-synuclein mitochondrial interaction leads to irreversible translocation and complex I impairment
Jimena H. Martínez,Federico Fuentes,Virginia Vanasco,Silvia Alvarez,Agustina Alaimo,Adriana Cassina,Federico Coluccio Leskow,Francisco Velazquez
Archives of Biochemistry and Biophysics. 2018; 651: 1
[Pubmed]  [Google Scholar] [DOI]
63 Comparing the Folds of Prions and Other Pathogenic Amyloids
José Flores-Fernández,Vineet Rathod,Holger Wille
Pathogens. 2018; 7(2): 50
[Pubmed]  [Google Scholar] [DOI]
64 Alpha-Synuclein Toxicity on Protein Quality Control, Mitochondria and Endoplasmic Reticulum
Thaiany Quevedo Melo,Sjef J. C. V. M. Copray,Merari F. R. Ferrari
Neurochemical Research. 2018;
[Pubmed]  [Google Scholar] [DOI]
65 Post-translational modifications of Parkinsonæs disease-related proteins: Phosphorylation, SUMOylation and ubiquitination
Stella C. Junqueira,Eduarda G.Z. Centeno,Kevin A. Wilkinson,Helena Cimarosti
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 2018;
[Pubmed]  [Google Scholar] [DOI]
66 Effect of rs3910105 in the Synuclein Gene on Dopamine Transporter Availability in Healthy Subjects
Youngduk Seo,Kyoungjune Pak,Hyun-Yeol Nam,Ju Won Seok,Myung Jun Lee,Eun-Joo Kim,Jae Meen Lee,Seong Jang Kim,In Joo Kim
Yonsei Medical Journal. 2018; 59(6): 787
[Pubmed]  [Google Scholar] [DOI]
67 Using Patient-Derived Induced Pluripotent Stem Cells to Identify Parkinson’s Disease-Relevant Phenotypes
S. L. Sison,S. C. Vermilyea,M. E. Emborg,A. D. Ebert
Current Neurology and Neuroscience Reports. 2018; 18(12)
[Pubmed]  [Google Scholar] [DOI]
68 Recent progress of drug nanoformulations targeting to brain
Abdur Rauf Khan,Xiaoye Yang,Manfei Fu,Guangxi Zhai
Journal of Controlled Release. 2018;
[Pubmed]  [Google Scholar] [DOI]
69 Formation of Heterotypic Amyloids: a-Synuclein in Co-Aggregation
Karishma Bhasne,Samrat Mukhopadhyay
PROTEOMICS. 2018; : 1800059
[Pubmed]  [Google Scholar] [DOI]
70 Ganglioside lipids accelerate a-synuclein amyloid formation
Ricardo Gaspar,Jon Pallbo,Ulrich Weininger,Sara Linse,Emma Sparr
Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics. 2018; 1866(10): 1062
[Pubmed]  [Google Scholar] [DOI]
71 Ginkgolide K promotes the clearance of A53T mutation alpha-synuclein in SH-SY5Y cells
Wenbo Yu,Sheng Chen,Liang Cao,Jie Tang,Wei Xiao,Baoguo Xiao
Cell Biology and Toxicology. 2017;
[Pubmed]  [Google Scholar] [DOI]
72 Familial Mutations May Switch Conformational Preferences in a-Synuclein Fibrils
Liang Xu,Buyong Ma,Ruth Nussinov,Damien Thompson
ACS Chemical Neuroscience. 2017;
[Pubmed]  [Google Scholar] [DOI]
73 Bone loss in C57BL/6J-OlaHsd mice, a substrain of C57BL/6J carrying mutated alpha-synuclein and multimerin-1 genes
Tamar Liron,Bitya Raphael,Sahar Hiram-Bab,Itai A. Bab,Yankel Gabet
Journal of Cellular Physiology. 2017;
[Pubmed]  [Google Scholar] [DOI]
74 a-Synuclein aggregation modulation: an emerging approach for the treatment of Parkinsonæs disease
Sushil K Singh,Aloke Dutta,Gyan Modi
Future Medicinal Chemistry. 2017; 9(10): 1039
[Pubmed]  [Google Scholar] [DOI]
75 iPS cells in the study of PD molecular pathogenesis
Melanie M. Cobb,Abinaya Ravisankar,Gaia Skibinski,Steven Finkbeiner
Cell and Tissue Research. 2017;
[Pubmed]  [Google Scholar] [DOI]
76 Up-regulation of autophagy-related gene 5 (ATG5) protects dopaminergic neurons in a zebrafish model of Parkinsonæs disease
Zhan-ying Hu,Bo Chen,Jing-pu Zhang,Yuan-yuan Ma
Journal of Biological Chemistry. 2017; 292(44): 18062
[Pubmed]  [Google Scholar] [DOI]
77 Small molecule probes of protein aggregation
Lydia M Young,Alison E Ashcroft,Sheena E Radford
Current Opinion in Chemical Biology. 2017; 39: 90
[Pubmed]  [Google Scholar] [DOI]
78 DT-diaphorase Protects Against Autophagy Induced by Aminochrome-Dependent Alpha-Synuclein Oligomers
Patricia S. Muñoz,Juan Segura-Aguilar
Neurotoxicity Research. 2017;
[Pubmed]  [Google Scholar] [DOI]
79 Synucleins and Gene Expression: Ramblers in a Crowd or Cops Regulating Traffic?
Alexei A. Surguchev,Andrei Surguchov
Frontiers in Molecular Neuroscience. 2017; 10
[Pubmed]  [Google Scholar] [DOI]
80 Role of Apolipoproteins and a-Synuclein in Parkinson’s Disease
Fatemeh Nouri Emamzadeh
Journal of Molecular Neuroscience. 2017;
[Pubmed]  [Google Scholar] [DOI]
81 Finding a new purpose for old drugs
Evan Y. Snyder
Science. 2017; 357(6354): 869
[Pubmed]  [Google Scholar] [DOI]
82 Correlation of Plasma EGF with Striatal Dopamine Transporter Availability in Healthy Subjects
Kyoungjune Pak,Seunghyeon Shin,So Jung Kim,Keunyoung Kim,Bum Soo Kim,Seong Jang Kim,In Joo Kim
Scientific Reports. 2017; 7(1)
[Pubmed]  [Google Scholar] [DOI]


Read this article